rss
Br J Ophthalmol 2008;92:1011-1012 doi:10.1136/bjo.2007.135681
  • Editorial

Avastin in myopic choroidal neovascularisation: is age the limit?

  1. David Wong1,2,
  2. Kenneth K W Li1
  1. 1
    Eye Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  2. 2
    St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
  1. Professor D Wong, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK; shdwong{at}liv.ac.uk
  • Accepted 20 January 2008

There are a growing number of publications supporting the use of Avastin (bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological myopia (table 1).1–8 In this issue, Arias et al (see page 1035) reported a prospective study of 17 patients;9 at the 6-month follow-up, the mean Early Treatment Diabetic Retinopathy Study visual acuity improved by 8.4 letters (p = 0.04), and the mean optical coherence tomography (OCT) foveal thickness decreased by 79.6 µm (p = 0.002). Is it time to change our clinical practice? Is it time to abandon photodynamic therapy (PDT) as the first line treatment? The purist would say that the only evidence base from randomised controlled trials is still that provided by the Verteporfin in Photodynamic Therapy (VIP) Study.10 11 In this study, PDT was shown to be effective in preventing visual loss fewer than eight letters in pathological myopia in the first year when compared with sham treatment.10 However, the effect of PDT was not sustained by the end of the second year.11 Smaller case series have shown similar results.11 Other investigators have attempted to improve the efficacy of PDT by enhancing the fluence13 or combining PDT with intravitreal triamcinolone acetonide injection.14 15 These studies failed to persuade, either limited by the small number …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.